VALENCIA, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by MannKind
Corporation (Nasdaq:MNKD) (TASE:MNKD), please note that in the first paragraph the date of the presentation should
be Thursday, January 12, 2017, not today as previously stated. The corrected release follows:
MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for diabetes,
will present on Thursday, January 12, 2017 at the 35th Annual J.P. Morgan Healthcare Conference at 10:00 AM (PST) at the
Westin St. Francis Hotel in San Francisco, California.
Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer.
Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's
website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients with
diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as
well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are
sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts
certain other information to the website.
Company Contact: Rose Alinaya SVP Finance 661-775-5300 ralinaya@mannkindcorp.com
